Skip to content

Study · Measured the body's own peptide · 2023

1 result

Gestational bisphenol A exposure advances puberty onset in female offspring: Critical time window identification.

Wang G, Xu G, Zhang C, Han A, Zhang G, Chen L, Xie G, Tao F, Shen T, Su P

Ecotoxicology and environmental safety9 Dec 2022Cited by 7 (Europe PMC)

PMID36508816 (opens in a new tab)DOI10.1016/j.ecoenv.2022.114387 (opens in a new tab)PepBankPUB-36508816
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In female mouse offspring, maternal BPA exposure in early and middle gestation increased serum levels of the body's own kisspeptin‑10 at PND 34.

    In plain wordsIn female mice, mothers' bisphenol A exposure in early and middle pregnancy raised the body's own kisspeptin‑10 in the offspring.

    Peptide
    Kisspeptin-10
    Outcome
    IncreaseSerum kisspeptin-10 at postnatal day 34
    Study

    mousen: not reported in source

    female CD-1 mouse offspring after maternal BPA exposure
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    We show that maternal BPA exposure during the early and middle gestational stages could advance the vaginal opening time and increase the serum levels of kisspeptin-10 and GnRH in the female offspring at PND 34.
    1 context sentence
    Summary · context
    Pregnant CD-1 mice were gavaged with BPA (8 mg/kg) daily during the early gestational stage (GD1-GD6), middle gestational stage (GD7-GD12) or late gestational stage (GD13-GD18).

    This result measures the body's own Kisspeptin-10. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.